Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
O Anticoagulante de Uso e Síntese BIB-953 é outro novo medicamento anticoagulante oral aprovado pela Food and Drug Administration dos EUA após a varfarina para prevenir acidente vascular cerebral e embolia em pacientes com fibrilação atrial não valvar. campo da terapia de anticoagulação e o campo da prevenção de trombose potencialmente fatal, e é um marco.
Grupo de Produto : Intermediários de API > Intermediário para CAS 872728-81-9
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Fill in more information so that we can get in touch with you faster
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.